1. Home
  2. ROL vs DGX Comparison

ROL vs DGX Comparison

Compare ROL & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rollins Inc.

ROL

Rollins Inc.

N/A

Current Price

$37.32

Market Cap

22.6B

Sector

Finance

ML Signal

N/A

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

N/A

Current Price

$243.93

Market Cap

23.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROL
DGX
Founded
1948
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.6B
23.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
ROL
DGX
Price
$37.32
$243.93
Analyst Decision
Buy
Buy
Analyst Count
11
13
Target Price
$64.73
$214.38
AVG Volume (30 Days)
5.2M
832.7K
Earning Date
04-22-2026
04-21-2026
Dividend Yield
1.32%
1.82%
EPS Growth
13.54
13.78
EPS
0.52
5.08
Revenue
$2,161,220,000.00
$11,035,000,000.00
Revenue This Year
$10.42
$7.53
Revenue Next Year
$8.86
$3.77
P/E Ratio
$70.98
$48.11
Revenue Growth
7.23
11.78
52 Week Low
$35.83
$171.18
52 Week High
$66.14
$245.68

Technical Indicators

Market Signals
Indicator
ROL
DGX
Relative Strength Index (RSI) 39.89 72.61
Support Level $36.59 $191.82
Resistance Level $61.59 N/A
Average True Range (ATR) 0.79 4.47
MACD 0.30 -0.24
Stochastic Oscillator 74.32 82.80

Price Performance

Historical Comparison
ROL
DGX

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: